|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Huntington's disease
|
Disease state |
|
|
PC3
|
Cell line |
|
|
Kidney
|
Organism part |
|
|
Peripheral blood
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Testis
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
Control
|
Compound treatment |
|
|
Uninfected
|
Infection |
|
|
Fibroblast
|
Cell type |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
BT-474
|
Cell line |
|
|
HL-60
|
Cell line |
|
|
T47D
|
Cell line |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Experimental malaria-infected
|
Disease state |
|
|
SKBR3
|
Cell line |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Primary gastric tumor
|
Organism part |
|
|
Methotrexate
|
Compound treatment |
|
|
Effector memory CD4 T cell
|
Target cell type |
|
|
Alveolar space neutrophil
|
Cell type |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Cerebellum
|
Organism part |
|
|
Enzo Labeling
|
Protocol type |
|
|
CXCR5(-)ICOS(-/lo) CD4 T cell
|
Target cell type |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Central memory 1 CD4 T cell
|
Target cell type |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Chondrocyte
|
Cell type |
|
|
Spermatocyte
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Rapamycin
|
Compound treatment |
|
|
Skin
|
Organism part |
|
|
BT474
|
Cell line |
|
|
MCF7
|
Cell line |
|
|
CXCR5(hi)ICOS(hi) CD4 T cell
|
Target cell type |
|
|
Proliferative
|
Developmental stage |
|
|
Differentiated
|
Developmental stage |
|
|
Normal
|
Disease staging |
|
|
Central memory CD4 T cell
|
Target cell type |
|
|
Lymph node
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Baseline uninfected
|
Disease state |
|
|
Benign nevi
|
Disease state |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Limited radiation toxicity
|
Clinical history |
|
|
Spleen
|
Organism part |
|
|
Immediately after exercise
|
Clinical info |
|
|
Heregulin
|
Compound treatment |
|
|
Testicular seminoma
|
Disease state |
|
|
Naive CD4 T cell
|
Target cell type |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
SM1
|
Cell line |
|
|
BL41K3
|
Cell line |
|
|
BJABK3
|
Cell line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Granulocyte
|
Cell type |
|
|
CXCR5(lo)ICOS(int) CD4 T cell
|
Target cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Grade IV
|
Tumor grading |
|
|
Glioblastoma
|
Disease state |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Acute radiation toxicity
|
Clinical history |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Crohn's disease
|
Disease state |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Symptomatic
|
Disease staging |
|
|
IgV mutated
|
Genotype |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Malignant melanoma
|
Disease state |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
60 min after exercise
|
Clinical info |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Seminiferous tubule
|
Organism part |
|
|
Cartilage
|
Organism part |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
Monocyte at intermediate diffe...
|
Cell type |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Epilepsy
|
Disease state |
|
|
GLI72
|
Cell line |
|
|
PT3
|
Disease staging |
|
|
None
|
Gene modification |
|
|
CD8+ naive CD8 T cell
|
Cell type |
|
|
KSHV-negative EBV-positive
|
Clinical info |
|
|
17beta-estradiol
|
Compound treatment |
|
|
Circulating neutrophil
|
Cell type |
|
|
MKN28
|
Cell line |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
Breast carcinoma
|
Disease state |
|
|
Johnsen score count 8: hypospe...
|
Histology |
|
|
N/a
|
Test result |
|
|
HaCaT
|
Cell line |
|
|
MDA-MB-231
|
Cell line |
|
|
ITM
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
Synovial fluid
|
Organism part |
|
|
In vitro neutrophil
|
Cell type |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
CD4+ T cell
|
Cell type |
|
|
CD8+ T cell
|
Cell type |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
CD56+ NK cell
|
Cell type |
|
|
Senescence bypassed
|
Phenotype |
|
|
Lymphoid tissue
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
ITM-E6E7
|
Cell line |
|
|
Epithelial cell
|
Cell type |
|
|
Stromal cell
|
Cell type |
|
|
IMP(1,3)B
|
RNAi |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
HTERT/HPVE6/HPVE7/SV40t/hRas t...
|
Gene modification |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
MDA468
|
Cell line |
|
|
BC-1
|
Cell line |
|
|
Met5A
|
Cell line |
|
|
ITS medium
|
Growth condition |
|
|
Inter-prandial lipid micelles ...
|
Growth condition |
|
|
ITS medium with albumin-bound ...
|
Growth condition |
|
|
Postprandial lipid micelles in...
|
Growth condition |
|
|
Not applicable
|
Histology |
|
|
Endothelial cell
|
Cell type |
|
|
Neo-resistant
|
Genotype |
|
|
Stroma from endometriotic nodu...
|
Organism part |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Down syndrome
|
Disease state |
|
|
Relapse 0; ER status ER+; brai...
|
Clinical info |
|
|
Grade III
|
Tumor grading |
|
|
IBL4
|
Cell line |
|
|
Monocyte
|
Cell type |
|
|
Mercaptopurine
|
Compound treatment |
|
|
Metastatic
|
Disease staging |
|
|
CD105+ endothelial
|
Cell type |
|
|
Native skin
|
Cell type |
|
|
Pseudomonas aeruginosa
|
Infection |
|
|
Caco-2
|
Cell line |
|
|
Erythrocyte
|
Cell type |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
ITV
|
Cell line |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
HGF stimulation
|
Growth condition |
|
|
Mock
|
RNAi |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
GLI60
|
Cell line |
|
|
CD19+ B-cell
|
Cell type |
|
|
Stage III/3
|
Disease staging |
|
|
Gastric cancer
|
Disease state |
|
|
Primary fibroblast
|
Cell type |
|
|
Skin substitute
|
Cell type |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Serum deprivation
|
Growth condition |
|
|
Jurkat
|
Cell line |
|
|
Control - 37 degree_C
|
Growth condition |
|
|
Hypothermic - 32 degree_C
|
Growth condition |
|
|
PT1
|
Disease staging |
|
|
HeLa
|
Cell line |
|
|
Lung
|
Organism part |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Superior cervical ganglion
|
Organism part |
|
|
CD11c+ dendritic cell
|
Cell type |
|
|
Molecular class type 1
|
Test result |
|
|
Molecular class type 2
|
Test result |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
CD8+ effector memory RA T cell
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Capra hircus
|
Organism |
|
|
Pancreas
|
Organism part |
|
|
T2N0M0
|
Disease staging |
|
|
CD14+ monocyte
|
Cell type |
|
|
TIVE
|
Cell line |
|
|
Beta cell islets
|
Organism part |
|
|
KSHV latent infection
|
Disease state |
|
|
ERalpha transfected
|
Genotype |
|
|
ERbeta transfected
|
Genotype |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Pan troglodytes
|
Organism |
|
|
Chronic myelogenous leukemia K...
|
Disease state |
|
|
Johnsen score count 7: many ea...
|
Histology |
|
|
CD34+
|
Cell type |
|